Clinical trial

Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC

NCT07754812

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-06-25

PhasePHASE4

Study timeline

Study start (actual)2026-06-25Date precision: day

Registry last updated2026-08-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC (Non-small Cell Lung Cancer)unresolved

Interventions

Oral Paclitaxel SolutionDRUG

PD-1/PD-L1 inhibitorDRUG

Stereotactic Body Radiotherapy (SBRT)RADIATION

Radical Lung Cancer SurgeryPROCEDURE

Stereotactic Body Radiotherapy (SBRT)RADIATION

Sponsors & collaborators

Shanghai Pulmonary Hospital, Shanghai, Chinalead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1 GuangzhouGuangdong, China1 HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07754812 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.